STUART, FL--(Marketwired - Oct 20, 2016) - iRemedy Healthcare, Inc., a SaaS business dedicated to enhancing practice profitability by providing the efficient distribution of products to and through healthcare organizations, today announced its engagement of J.Streicher Capital LLC as exclusive capital market advisor and placement agent for the Company.
Founded in 1910, J. Streicher, pronounced "striker," provides advisory clients across numerous spectrums with high quality investment banking and capital market advisory services within the small cap and middle markets. In support of iRemedy's dynamic growth, J. Streicher will work with iRemedy's executive leadership to guide them through due diligence, valuation and strategic capital formation processes.
"We are very pleased to be teaming with J. Streicher and look forward to leveraging the firm's longstanding reputation, market influence and deep strategic capital advisory capabilities to assist us in accessing the capital necessary to perpetuate and accelerate our Company's strong growth momentum," noted Tony Paquin, President and CEO of iRemedy Healthcare.
About iRemedy Healthcare
Headquartered in Stuart, Florida, iRemedy is a Software-as-a-Service (SaaS) business dedicated to providing ecommerce solutions to physician practices, ambulatory surgery centers and other healthcare organizations. iRemedy enables its clients to reduce costs and generate new revenues through its Buy, Sell and Connect feature set. The Company's "Buy" product is iRemedy Supply (iremedysupply.com), an ecommerce site that offers quick access and competitive prices on brand name medical products to healthcare organizations. The Company's "Sell and Connect" offering is iRemedy Pro, a white labeled consumer focused ecommerce solution that enables provider-to-patient medical product sales. iRemedy's mission is to help its clients (providers) sustain financial viability while enhancing trusted patient relationships.
Contact Information:
FOR MORE INFORMATION, PLEASE CONTACT:
Dodi Handy
407-960-4636
iRemedy@wallstreetwriter.com